vimarsana.com

Page 16 - தேசிய நிறுவனம் ஆஃப் குழந்தை ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Questions raised over govt s back-pedalling on Rs1 25bn rabies control scheme - Pakistan

Dr Qazi named NICH Board member

Drug to Delay T1D Gets Tepid Endorsement by FDA Advisors

email article Teplizumab got a reticent thumbs-up from FDA advisors for an indication in delaying progression of at-risk patients to clinical type 1 diabetes (T1D). The agency s Endocrinologic and Metabolic Drugs Advisory Committee on Thursday voted 10-7 that sufficient evidence of benefit outweighed the risks for this novel biologic. However, a number on both sides indicated how narrowly they had come to making the opposite decision. I voted yes but had my finger over the no button for a long time, said Jack Yanovski, MD, PhD, chief of the Section on Growth and Obesity at the National Institute of Child Health and Human Development in Bethesda, Maryland.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.